Medtronic Completes MiniMed Separation (MDT)

Medtronic's completion of the MiniMed separation formally moves the Diabetes operating unit into an independent entity, MiniMed Group, Inc. For the nine months ended Jan. 23, 2026, Diabetes accounted for $2,774 million of Medtronic's $26,557 million total net sales, or about 10.4% of reported sales. On a full-year FY2025 basis, Diabetes represented approximately 8% of $33,537 million total net sales. Management has stated portfolio optimization and sharper strategic focus as the rationale for separating the Diabetes business. The company previously communicated a timeline to complete the Diabetes separation within 18 months of announcement; the completion announced today is the material corporate action aligned with that portfolio strategy. The separation was implemented alongside restructuring activity that the company recorded beginning Dec. 2025, including a $16 million charge reported in Q3 FY2026 and additional program costs allocated across restructuring, cost of goods sold and SG&A.

The MiniMed separation should be viewed in the broader context of Medtronic's multi-segment portfolio and capital priorities. For the nine months ended Jan. 23, 2026, Medtronic reported total net sales of $26,557 million across four reportable segments: Cardiovascular ($10,179 million, 38.3%), Neuroscience ($7,537 million, 28.4%), Medical Surgical ($7,323 million, 27.6%) and Diabetes ($2,774 million, 10.4%). Geographically, roughly half of sales were in the U.S. (about $13,234 million) and half international (about $13,218 million). Separating MiniMed aligns with stated management goals—portfolio optimization and operational focus—and follows prior capital-allocation moves such as a $5.0 billion share repurchase authorization and selective M&A (for example, the option to acquire CathWorks announced earlier). Investors should note the company has financed R&D partnerships and faces ongoing restructuring, tax, legal and regulatory items disclosed in filings; the separation is one element of that broader programmatic activity.